Giovanni Marconi, MD¹, Alfonso Piciocchi, MS^2*, Ernesta Audisio, MD^3*, Cristina Papayannidis, MD⁴, Fabio Guolo, MD, PhD^5,6*, Marco Cerrano, MD^7*, Valentina Arena, MS^2*, Capria Saveria^8*, Michela Rondoni^9*, Matteo Giovanni Della Porta, MD^10*, Geramana Beltrami^11*, Monica Bocchia, MD^12*, Albana Lico, MD^13*, Luisa Giaccone, MD, PhD^14*, Marianna Rossi, MD^15*, Catello Califano, MD^16*, Matteo Giovanni Carrabba^17*, Chiara Cattaneo, MD¹⁸, Marco Frigeni, MD^19*, Maria Chiara Di Chio^20*, Bianca Serio^21*, Roberto Freilone, MD^22*, Antonio Curti, MD, PhD²³, Paola Minetto, MD²⁴, Giovanni Marsili^25*, Clara Minotti^26*, Beatrice Zannetti^27*, Francesca Cotugno^25*, Jacopo Nanni, MD^28*, Giorgia Simonetti, PhD^29*, Maria Teresa Bochicchio^29*, Sara Rosellini^30*, Elisabetta Tedone^31*, Adriano Venditti, MD³², Roberto Massimo Lemoli, MD^33,34*, Marco Vignetti, MD^35*, Paola Fazi, MD^2* and Giovanni Martinelli^36*

¹IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”,, Meldola, Italy
²GIMEMA Foundation, Data Center and Health Outcomes Research Unit, Rome, Italy
³SC Ematologia 2, AOU Città della Salute e della Scienza, Turin, Italy
⁴Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy
⁵Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
⁶Clinic of Hematology, Department of Internal Medicine (DiMI), Policlinico San Martino, IRCCS per l’Oncologia, University of Genoa, Genoa, Italy
⁷Division of Hematology, Department of Oncology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
⁸Policlinico Umberto I, Ematologia, Roma, Italy
⁹Hematology Unit & Metropolitan Transplant Network, AUSL Romagna, Ravenna, Italy
¹⁰Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
¹¹IRCSS S. Martino, Hematology and Transplant Unit, Genova, Italy
¹²UOC Ematologia, Azienda ospedaliero-universitaria Senese, Siena, Italy
¹³Hematology Unit, San Bortolo Hospital, Vicenza, Italy, Vicenza, Italy
¹⁴Univesity of Torino, AOU Città Della Salute E Della Scienza Di Torino,, Torino, ITA
¹⁵Division of Hematology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy, Pavia, ITA
¹⁶EMATOLOGIA, ASL SALERNO, PRESIDIO OSPEDALIERO TORTORA PAGANI, Pagani, ITA
¹⁷Unit of Hematology and Bone Marrow Transplantation, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
¹⁸Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁹Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy, Bergamo, Italy
²⁰Istituto Nazionale Tumori, Milano, Italy
²¹University Hospital "san Giovanni Di Dio E Ruggi D'Aragona", Salerno, ITA
²²Hematology Division, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
²³IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
²⁴Clinica Ematologica, Dipartimento di Oncologia e Ematologia, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
²⁵Fondazione Gimema, Roma, Italy
²⁶Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ITA
²⁷Hematology Unit & Metropolitan Transplant Network, Ravenna and Stem Cell Transplant, AUSL Romagna, Ravenna, Italy
²⁸Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy
²⁹IRCSS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l, Meldola, Italy
³⁰Servizio di Citofluorimetria, Dipartimento di Anatomia Patologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
³¹IRCCS Ospedale Policlinico San Martino, Genoa, Italy
³²Department of Onco-Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy, Italy
³³Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy, Genoa, Italy
³⁴Clinic of hematology, Department of Internal medicine (DiMI), University of Genoa, Genoa, Italy
³⁵GIMEMA Foundation, Rome, Italy
³⁶IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Medola, Italy

Martin Hutchings, MD, PhD^1*, Pau Montesinos, PhD, MD^2*, Armando Santoro, MD^3*, Hsin-An Hou^4*, Maria Pilar Martinez-Sanchez, MD^5*, Susana Vives^6*, Sara Galimberti, MD, PhD^7*, Tsai-Yun Chen, MD^8*, Marco Frigeni, MD^9*, Sylvain Garciaz^10*, Olga Salamero, MD^11*, Su-Peng Yeh, MD^12*, Karen Yee, MD^13*, Gabriel Schnetzler, MD^14*, Teresa Barata^15*, Silke Simon, PharmD, PhD^16*, Heather Hinton^17*, Koorosh Korfi, PhD¹⁸, Muriel Richard, PharmD, PhD^18*, Nino Keshelava, MD^18* and Marion Subklewe, MD¹⁹

¹Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
²Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
³Humanitas University, Pieve Emanuele, Milan, Italy
⁴National Taiwan University Hospital, Taipei, TWN
⁵hospital universitario 12 de octubre, Madrid, Spain
⁶Hospital Germans Trias i Pujol, Badalona, ESP
⁷Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
⁸National Cheng-Kung Univ. Hospital, Tainan, TWN
⁹Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy, Bergamo, Italy
¹⁰Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France
¹¹Hospital Vall d'Hebron, Barcelona, Barcelona, ESP
¹²Department of Internal Medicine, China Medical University Hospital, Taichung City, TWN
¹³Princess Margaret Cancer Center (PMCC), Toronto, ON, CAN
¹⁴Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center, Basel, Switzerland
¹⁵15 Roche Product Development, Data Science, Roche Innovation Center, Basel, Switzerland
¹⁶Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland
¹⁷Pharma Development, Roche Innovation Center Basel, Switzerland, Basel, Switzerland
¹⁸Roche Pharma Research and Early Development, Discovery & Translational Area Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland
¹⁹Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany

Klaus Geissler, MD^1,2*, Zdenek Koristek, MD, PhD^3*, Teresa Bernal Del Castillo, MD, PhD^4*, Jan Novak^5*, Gabriela Rodriguez Macias, MD⁶, Stephan Metzelder^7*, Arpad Illes, MD^8*, Agnes Nagy, MD^9*, Jiří Mayer, MD¹⁰, Montserrat Arnan Sangerman, MD, PhD^11*, Mary-Margaret Keating, MD¹², Jürgen Krauter^13*, Monia Lunghi, MD, PhD^14*, Nicola Fracchiolla, MD^15*, Uwe Platzbecker, MD¹⁶, Valeria Santini¹⁷, Danna Chan, PhD^18*, Beloo Mirakhur, MD, PhD¹⁸, Yuri Sano, MD, PhD¹⁸, Aram Oganesian, PhD^18*, Harold N. Keer, MD, PhD¹⁸ and Michael Lübbert, MD¹⁹

¹Clinic Hietzing, Vienna, Austria
²Sigmund Freud University, Vienna, AUT
³University Hospital Ostrava, Ostrava, CZE
⁴Hospital Universitario Central de Asturias, ISPA, IUOPA, Oviedo, Spain
⁵Charles University and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic
⁶Hospital Universitario Gregorio Maranon, Madrid, ESP
⁷Philipps-Universität Marburg, Marburg, Germany
⁸Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
⁹University of Pécs, University of Pécs, Hungary
¹⁰Masaryk University and University Hospital Brno, Brno, Czech Republic
¹¹Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain
¹²Queen Elizabeth II (QEII) Health Sciences Centre, Halifax, NS, CAN
¹³Department of Hematology and Oncology, Städtisches Klinikum Braunschweig, Braunschweig, Germany
¹⁴Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
¹⁵Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
¹⁶Department of Hematology, University Hospital of Leipzig, Leipzig, Germany
¹⁷MDS Unit, AOU Careggi, DMSC, University of Florence, Firenze, Italy
¹⁸Astex Pharmaceuticals, Inc., Pleasanton, CA
¹⁹University Medical Center Freiburg, Freiburg, Germany

Gail J. Roboz, MD¹, Laura E. Finn, MD², Johnnie J. Orozco, MD, PhD³, Mohamed Hegazi, MD⁴, Avinash Desai, M.D^5*, Mary Chen⁶ and Gary J. Schiller, MD⁷

¹Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY
²Ochsner Cancer Center, New Orleans, LA
³Translational Science and Therapeutics Division, Fred Hutch Cancer Research Center, Seattle, WA
⁴University of Louisville School of Medicine, Louisville, KY
⁵Actinium Pharmaceuticals, New York, NY
⁶Actinium Pharmaceuticals, New York
⁷Hematological Malignancy/ Stem Cell Transplant Program, David Geffen School of Medicine, UCLA, Los Angeles, CA

Niklas Beumer, MSc^1,2,3,4,5,6*, Jonas S. Waizenegger, MD^1,2,3,4,7*, Michael Heuser, MD^8,9, Jörg Chromik, MD^10*, Grerk Sutamtewagul, MD¹¹, Silke Kapp-Schwoerer, MD^12,13*, Monica Crugnola, MD^14*, Nicola Di Renzo, MD^15*, Roberto M. Lemoli, MD^16*, Daniele G. Mattei, MD¹⁷, Walter Fiedler, MD¹⁸, Yesid Alvarado-Valero, MD^19*, David Micklem, PhD^20*, Linn H. Nilsson, PhD^20*, Noelly Madeleine, PhD^20*, Nigel McCracken, PhD^21*, Cristina Oliva, MD^21*, Claudia Gorcea-Carson, MD^21*, Lisa-Marie Rieckmann, MSc^1,2,3,4*, Jenny Krause, MD^22*, Victoria Gensch^1,2,3,4,7*, Isabel Ben Batalla, PhD^1,2,3,4*, Melanie Janning, MD^1,2,3,4,7*, Nicola Gagliani, MD^23*, Benedikt Brors, PhD^6,24,25*, Charles D. Imbusch, PhD^6*, Bjorn T. Gjertsen, MD, PhD^26,27 and Sonja Loges, MD, PhD^1,2,3,4,7*

¹DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany
²Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
³Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany
⁴German Center for Lung Research (DZL), Heidelberg, Germany
⁵Faculty of Biosciences, Heidelberg University, Heidelberg, Germany
⁶Division of Applied Bioinformatics (B330), German Cancer Research Center (DKFZ), Heidelberg, Germany
⁷University Medical Hospital Hamburg-Eppendorf, II. Medical Clinic, Hamburg, Germany
⁸Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁹Comprehensive Cancer Center Niedersachsen, Hannover Medical School, Hannover, Germany
¹⁰University Hospital Frankfurt, Frankfurt, Germany
¹¹University of Iowa Hospitals and Clinics, Iowa City, IA
¹²University Hospital of Ulm, Ulm, Germany
¹³Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany
¹⁴University of Parma, Parma, Italy
¹⁵Haematology, Ospedale V. Fazzi, Lecce, Italy, Lecce, Italy
¹⁶University of Genoa, Genoa, Italy
¹⁷ASO S. Croce e Carle, Cuneo, Italy
¹⁸University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁹The University of Texas M.D. Anderson Cancer Center, Houston, TX
²⁰BerGenBio ASA, Bergen, Norway
²¹BerGenBio Ltd, Oxford, United Kingdom
²²Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²³University Medical Hospital Hamburg-Eppendorf, I. Medical Clinic, Hamburg, Germany
²⁴German Cancer Consortium (DKTK), Heidelberg, Germany
²⁵National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany
²⁶Haukeland University Hospital, Bergen, Norway
²⁷Center for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway

Guru Subramanian Guru Murthy, MBBS¹, Jessica T. Leonard, MD², Talha Badar, MD³, Cecilia Y. Arana Yi, MD⁴, Adam S Duvall, MD⁵, Bijal D. Shah, MD⁶, Arielle Baim^7*, Tyce Kearl, MD^8*, Alexandra M. Harrington, MD, MT(ASCP)⁷, Aniko Szabo, PhD^7* and Ehab L. Atallah, MD⁹

¹Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
³Mayo Clinic, Jacksonville, FL
⁴Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
⁵Department of Medicine, University of Chicago, Chicago, IL
⁶Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁷Medical College of Wisconsin, Milwaukee, WI
⁸Division of Hematology/Oncology, Medical College of Wisconsin, MIlwaukee, WI
⁹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI

Lisa Ivanschitz, PhD^1*, Josée Hue-Perron, PhD^1*, Léo Marx, PhD^2*, Marie-Claude Roubaudi-Fraschini, PhD^1*, Caroline Peet, PhD^1*, Nathalie Bellocq, PhD^2*, Riccardo Colombo, PhD^1*, Karilyn T. Larkin, MD³ and Esthela Artiga, MS^4*

¹Debiopharm International, Lausanne, Switzerland
²Debiopharm Research & Manufacturing SA, Martigny, Switzerland
³Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH

Astghik Voskanyan, MD^1,2*, Maria Badikyan, MD^1,2*, Marina Y. Konopleva^3,4, Alvaro J. Alencar, MD⁵, Arusyak Ivanyan, MD^1*, Carolyn Owen, MD⁶, Consolato Sergi, MD, PhD, MPH, FRCPC, FCAP^7*, Ching-Tien Peng, MD^8*, Dickran Kazandjian, MD⁹, Funda Tekkesin, MD^10*, Hasanein Ghali, MD^11*, Karen Bedirian, BSc, MPH^1,2,12*, Maria Paola Martelli, MD, PhD^13*, Enrico Attardi, MD^14*, Maria Teresa Voso, MD¹⁵, Mariam Abramashvili, MD^16*, Mazin Faisal Al-Jadiry, MD^11*, Michalis Michael, MD^17*, Min-Yu Su, MD^8*, Nare Martirosyan, MD^1*, Nino Totogashvili, MD^16*, Pavel P Kotoucek, MD, PhD^18*, Rejin Kebudi, MD^19*, Robin Ohannessian, MD^20*, Ruzanna Papyan, MD^1,2,21,22, Salma Elashwah, MD^23*, Sameer Bakhshi, MD^24*, Samvel Bardakhchyan, MD, PhD^1,2*, Samvel Danelyan, MD, PhD^1*, Shaimaa El-Ashwah, MD^25*, Tezer Kutluk, MD, PhD^26*, Gevorg Tamamyan, MD, MSc, PhD, DSc^1,2,21,22* and Naveen Pemmaraju, MD²⁷

¹Hematology Center after Prof. Yeolyan, Yerevan, Armenia
²Immune Oncology Research Institute, Yerevan, Armenia
³Albert Einstein College of Medicine, Bronx, NY
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
⁶University of Calgary, Calgary, AB, Canada
⁷Children’s Hospital of Eastern Ontario (CHEO), University of Ottawa, Ottawa, Canada
⁸China Medical University Children’s Hospital, Taichung, Taiwan
⁹Myeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami
¹⁰9. University of Health Sciences, Umraniye Research and Education Hospital, Pediatric Hematology and Oncology Department, Pediatric Bone Marrow Transplantation Unit, Istanbul, Turkey
¹¹10-Department of Pediatrics, College of Medicine, University of Baghdad, Oncology Unit-Children Welfare Teaching Hospital-Medical City, Baghdad, Iraq
¹²Immune Oncology Research Institute, Yerevan, ARM
¹³Hematology, Department of Surgery and Medicine, University of Perugia and ‘Santa Maria della Misericordia’ Hospital, Perugia, Italy
¹⁴Department of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, Italy
¹⁵Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
¹⁶M. Iashvili Children's Central Hospital, Tbilisi, Georgia
¹⁷Cyprus Society of Haematology, Nicosia, Cyprus
¹⁸Broomfield Hospital, Haematology Mid and South Essex University Hospitals Group, Chelmsford, Essex, Essex, United Kingdom
¹⁹16. Istanbul University, Oncology Institute, Istanbul, TUR
²⁰Telemedicine 360 by Telemonica, Paris, France
²¹Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. R. H. Yeolyan, Yerevan, Armenia
²²Department of Pediatric Oncology and Hematology, Yerevan State Medical University, Yerevan, Armenia
²³Medical Oncology Unit, Oncology Center Mansoura University (OCMU), Faculty of Me, Mansoura, Egypt
²⁴Department of Medical Oncology, Dr. B.R.A Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Dehli, India
²⁵Oncology Center, Mansoura University Faculty of Medicine, Mansoura, Egypt
²⁶Turkish Pediatric Cancer Registry, Ankara, Turkey
²⁷Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Ola A. Elgamal, PhD¹, Juan Carlos Zapata, PhD^2*, Haishan Li, PhD^2*, Chia Sharpe, PhD^1*, Sydney Fobare, PhD^1,3, Blaise Stearns, M.Sc^1*, James R. Lerma^1*, Kinsey Bryant^1*, Casie Furby^1*, Marissa Long^1*, Kaytlynn Fyock^1*, Megan E. Johnstone, PhD^1*, Thomas M. Sesterhenn^1*, Benjamin Wronowski^1*, Jianmin Pan^4*, Shesh N. Rai, PhD^4*, Andrew Orry, PhD^5*, Polo Chun-Hung Lam, PhD^5*, Ruben Abagyan, PhD^5*, Alexei Pushechnikov, PhD^6*, Nikolay Savchuk, PhD^7*, Volodymyr Kysil, PhD^6*, Hovhannes Gukasyan, PhD^6*, Iain Dukes, DPhil^7*, Kate Dokukina, MD, PhD^7*, Oleg Mitkin, PhD^6*, Ruben Karapetian, PhD^6*, Alexey Ryakhovskiy, PhD^6*, Elena Bulanova, PhD^6*, Vladislav Parchinsky, PhD^6*, Alexandre Ivachtchenko, PhD^6*, Daniel T. Starczynowski, PhD⁸, Amy Burd, PhD^7*, C. David Pauza, PhD^2*, Erin K. Hertlein, PhD¹ and John C. Byrd, MD¹

¹Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
²Viriom Inc, San Diego, CA
³Medical Scientist Training Program, The Ohio State University, Columbus, OH
⁴Division of Biostatistics and Bioinformatics, Department of Environmental and Public Health Sciences, University of Cincinnati, Cincinnati, OH
⁵MolSoft LLC, San Diego, CA
⁶ChemDiv Inc, San Diego, CA
⁷Eilean Therapeutics, Philadelphia, PA
⁸Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Tapan M. Kadia, MD¹, Hagop Kantarjian, MD¹, Gheath Alatrash, PhD, DO², Anna Sergeeva, PhD^3*, Hong He, MD, PhD^3*, Lisa St. John^4*, Priya Koppikar, PhD⁵, Celine Kerros, PhD^6*, Karen Clise-Dwyer, PhD^7*, Kathryn Ruissard^8*, Abhishek Maiti, MD¹, Courtney D. DiNardo, MD, MSc¹, Elias Jabbour⁹, Srdan Verstovsek¹⁰, Naveen Pemmaraju, MD¹¹, Nitin Jain, MD¹, Ghayas C. Issa¹², Guillermo Garcia-Manero, MD¹³, Guillermo Montalban-Bravo, MD¹, Aditi Shastri, MD¹⁴, Daniel R. Couriel, MD, MS, MBA¹⁵, Maria Rhona Pinsoy, BSN^16*, Sapna Parshottham^16*, Richard E. Champlin, MD¹⁷, Jorge Cortes, MD¹⁸ and Jeffrey J. Molldrem, MD¹⁹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Pearland, TX
³Department of Hematopoietic Biology and Malignancy, University of Texas M. D. Anderson Cancer Center, Houston, TX
⁴Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston
⁵ECLIPSE, Therapeutics Discovery and Development, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁶ECLIPSE, Therapeutics Discovery and Development, University of Texas M. D. Anderson Cancer Center, Houston, TX
⁷Department of Hematopoietic Biology & Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston
⁸Flow Cytometry Core Facility, University of Texas M. D. Anderson Cancer Center, Houston, TX
⁹University of Texas M.D. Anderson Cancer Ctr., Houston, TX
¹⁰MD Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, MD Anderson Cancer Center, Houston, TX
¹²The University of Texas MD Anderson Cancer Center, Houston, TX
¹³University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
¹⁵Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁶The University of Texas M.D. Anderson Cancer Center, Houston
¹⁷Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁸Georgia Cancer Center, Augusta University, Augusta, GA
¹⁹Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX

Marcello Rotta, MD^1*, Farhad Ravandi, MD, MBBS², Mitul Gandhi, MD³, Paul B. Koller, MD⁴, Gary J. Schiller, MD⁵, Courtney Follit^6*, Mona Vimal, MS^6*, Stephan W. Morris, MD^6*, Sanchita Mourya, MD^6*, Thomas Butler, MS, MBA^6* and Eunice S. Wang, MD⁷

¹Colorado Blood Cancer Institute, Denver, CO
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³US Oncology Site - Virginia Cancer Specialists, Fairfax, VA
⁴Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁵Hematological Malignancy/ Stem Cell Transplant Program, David Geffen School of Medicine, UCLA, Los Angeles, CA
⁶Biomea Fusion, Redwood City, CA
⁷Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Jan Philipp Bewersdorf, MD¹, Namrata Sonia Chandhok, MD², Justin M. Watts, MD³, Andriy Derkach, PhD^4*, Omar Abdel-Wahab, MD⁵, Eytan M. Stein⁶ and Justin Taylor, MD⁷

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Division of Hematology, University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center, Miami, FL
³Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, MIAMI, FL
⁴Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL

Courtney D. DiNardo, MD, MSc¹, Stephen Anthony Strickland, MD², Barry Skikne, MD^3*, Amer M. Zeidan, MBBS, MHS⁴, Elie Traer, MD, PhD⁵, Hetty E. Carraway, MD, MBA⁶, Stanley R Frankel, MD⁷, Daniel E Weiss, MD^8*, Jacky H Wang, PhD^8*, Steven Pirie-Shepherd, PhD^9*, Joseph Piccotti, PhD^9*, D. Hamish Wright⁸ and Karen Akinsanya^8*

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Sarah Cannon Research Institute, Nashville, TN
³University of Kansas Cancer Center, Kansas City, KS
⁴Section of Hematology, Department of Internal Medicine, Yale University School of Medicine - Yale Cancer Center, New Haven, CT
⁵Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR
⁶Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
⁷Columbia University Vagelos College of Physicians and Surgeons, New York, NY
⁸Schrödinger, Inc., New York, NY
⁹Schrödinger, Inc., San Diego

Eric S. Winer, MD¹, Jacqueline S. Garcia, MD², Richard M Stone, MD¹, Martha Wadleigh, MD¹, Marlise R. Luskin, MD, MSCE¹, Maximilian Stahl, MD³, Evan C. Chen, MD¹, Rebecca Leonard^2*, Alexis Noyes^1*, Ilene Galinsky, ANP², Rashmi Deshpande^4*, Pascal Borderies, MD^4*, Vincent O'Neill, MD^4* and Daniel J. DeAngelo¹

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Dana Farber Institute, Boston, MA
⁴BioXcel Therapeutics, New Haven, CT

Gina Keiffer, MD¹, Bruno Calabretta, MD, PhD^2*, Alexander Mazo, PhD^2*, Ubaldo Martinez Outschoorn, MD¹, Onder Alpdogan, MD^1*, Adam F. Binder, MD¹, Pierluigi Porcu, MD³, Lindsay Wilde, MD⁴ and Margaret Kasner, MD¹

¹Sidney Kimmel Cancer Center, Thomas Jefferson University, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Philadelphia, PA
²Department of Pharmacology, Physiology and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
³Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
⁴Sidney Kimmel Cancer Center, Jefferson Health, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Philadelphia, PA

Gina Keiffer, MD¹, Sara E. Meyer, PhD², Christine Eischen, PhD^3*, Ubaldo Martinez Outschoorn, MD¹, Onder Alpdogan, MD^1*, Adam F. Binder, MD¹, Pierluigi Porcu, MD⁴, Lindsay Wilde, MD⁵, Margaret Kasner, MD¹ and Neil Palmisiano, MD, MS⁶

¹Sidney Kimmel Cancer Center, Thomas Jefferson University, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Philadelphia, PA
²Department of Pharmacology, Physiology, and Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
³Thomas Jefferson University, Philadelphia, PA
⁴Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
⁵Sidney Kimmel Cancer Center, Jefferson Health, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Philadelphia, PA
⁶Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Elisabeth Wieduwild, PhD^1*, Anne-Charlotte Le Floch, MBBS, MSc^2*, Céline Garulli^1*, Caroline Imbert, PhD^3*, Aude De Gassart, PhD^1*, Patrick Brune^1*, Katrien Lemmens, MD, PhD^1*, Sylvain Garciaz^4*, Abhishek Maiti, MD⁵, Pierre Peterlin^6*, Celine Leparquier^7*, Marina Iche^7*, Norbert Vey, MD⁸, Daniel Olive, MD, PhD^9* and Paul Frohna^10*

¹ImCheck Therapeutics, Marseille, France
²Aix, Marseille, France
³Institut Paoli Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), MARSEILLE, France
⁴Hematology Department, Integrative Structural and Chemical Biology, Aix-Marseille Université, Inserm, CNRS, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Hematology Department, Hôpital Hotel Dieu, NANTES CEDEX 1, France
⁷ILife Consulting, Paris, France
⁸Department of Hematology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille, France
⁹Institut Paoli Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France
¹⁰Imcheck Therapeutics, Marseille, France

Aaron D. Goldberg, MD, PhD¹, Daniel Corum, Ph.D.^2*, Julie Ahsan, MS^3*, Kun Nie, PhD^2*, Tom Kozlek, MD^3*, Mollie Leoni, MD^4* and Stephen Dale, MD^3*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Kura Oncology, San Diego, CA
³Kura Oncology, Boston, MA
⁴Kura Oncology, Princeton, NJ

Brittany Knick Ragon, MD¹, John Bomalaski, MD^2*, Amanda Johnston, PhD^2*, Mirla Langlois, MD, PhD^2*, Nicole DeFord Chang^2* and Gautam Borthakur, MD³

¹Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
²Polaris Pharmaceuticals, Inc., San Diego, CA
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Ana Alfonso Pierola, M.D., Ph.D.^1*, Stephane De Botton, MD, PhD^2*, Jun Ho Jang, MD, PhD³, Victoria Campbell, MD, PhD^4*, Jenny O'Nions, MBBCh, PhD, MRCP, FRCPath^5*, Maria Calbacho^6*, Annette L. Ervin-Haynes, DO^7*, Kristen Keagle, BSN^7*, Aline Maillard, PhD^8*, Maud Beneton, PharmD, PhD^9*, Mathilde Romagnoli^10* and Alberto Broniscer, MD, MSc⁷

¹Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
²Department of Hematology, Institut Gustave Roussy, Villejuif, France
³Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁴Department of Hematology, Western General Hospital, Edinburgh, United Kingdom
⁵University College London NHS Foundation Trust, London, United Kingdom
⁶Hospital Universitario 12 de Octubre, Madrid, Spain
⁷Therapeutic Area Oncology, Servier Pharmaceuticals, Boston, MA
⁸Biostatistics, Servier, Suresnes, France
⁹Translational Medicine, Servier, Gif sur Yvette, France
¹⁰Translational Medicine, Servier, GIF SUR YVETTE, ILE DE FRANCE, France